GSK:NYSE
GSK plc
50,45 US$
arrow_upward
+0,52%(+0,26) 1D
50,45 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 13 ნოე, 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
50,25 US$
High
50,80 US$
Low
50,13 US$
Mkt. cap
101,75 მლრ.
Avg. vol.
5,06 მლნ.
Volume
2,78 მლნ.
Dividend
3,64%
Quarterly dividend
0,46 US$
Ex-dividend date
12 ნოე. 2026
P/E ratio
17,85
52-wk high
61,70 US$
52-wk low
45,80 US$
EPS
2,83 US$
Beta
0,20
Shares outstanding
2,02 მლრდ.
No. of employees
67 ათ.
Open
50,25 US$
High
50,80 US$
Low
50,13 US$
Mkt. cap
101,75 მლრ.
Avg. vol.
5,06 მლნ.
Volume
2,78 მლნ.
Dividend
3,64%
Quarterly dividend
0,46 US$
Ex-dividend date
12 ნოე. 2026
P/E ratio
17,85
52-wk high
61,70 US$
52-wk low
45,80 US$
EPS
2,83 US$
Beta
0,20
Shares outstanding
2,02 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
The Motley Fool
·
50 წუთის წინ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
6 საათის წინ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
24/7 Wall St.
·
3 საათის წინ
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
3 საათის წინ
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOემა უოლმსლი | ემა უოლმსლი
Employees66,8 ათ.
Founded27 დეკ. 2000
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitegsk.com